Neurocrine Biosciences (NBIX) earnings per share (EPS)

Earnings per share · fiscal 2025
$4.67

Neurocrine Biosciences (NBIX) reported diluted earnings per share of $4.67 in fiscal 2025 (the year ended December 31, 2025). That is 41.9% higher than the $3.29 of fiscal 2024. Figures as of 18 Nov 2026, 01:51 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings per share, fiscal 2025
$4.67
Change on fiscal 2024
+41.9%
Growth, 5 years
+2.3% a year
Highest on record
$4.67fiscal 2025
Lowest on record
-$1.63fiscal 2016
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Neurocrine Biosciences earnings per share (EPS), in more detail

Over the five fiscal years to 2025 diluted earnings per share grew at a compound 2.3% a year. Across the 17 fiscal years on record (2009–2025), the highest was $4.67 in fiscal 2025 and the lowest -$1.63 in fiscal 2016.

History · 17 fiscal years

Earnings per share by fiscal year

Neurocrine Biosciences earnings per share (EPS), year by year

Neurocrine Biosciences (NBIX) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2025$4.67 41.9% up
2024$3.29 33.2% up
2023$2.47 58.3% up
2022$1.56 69.6% up
2021$0.92 77.9% down
2020$4.16 966.7% up
2019$0.39 77.3% up
2018$0.22—
2017-$1.62—
2016-$1.63—
2015-$1.05—
2014-$0.81—
2013-$0.69 962.5% down
2012$0.08 88.1% down
2011$0.67—
2010-$0.15—
2009-$1.30—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

Earnings per share at health care companies of similar size

Earnings per share of Neurocrine Biosciences and comparable companies
CompanyEarnings per shareFiscal year
Revvity RVTY$2.072025
Exelixis EXEL$2.782025
Charles River Laboratories International CRL-$2.912025
Neurocrine Biosciences NBIX$4.672025
Ascendis Pharma ASND-€3.762025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on NBIX

Neurocrine Biosciences, figure by figure

Neurocrine Biosciences (NBIX) overview: price, valuation and scorecardAll health care companies by market value

Neurocrine Biosciences earnings per share (EPS): questions and answers

What is Neurocrine Biosciences's diluted earnings per share?

Neurocrine Biosciences (NBIX) reported diluted earnings per share of $4.67 in fiscal 2025 (the year ended December 31, 2025). That is 41.9% higher than the $3.29 of fiscal 2024.

What is the growth rate of Neurocrine Biosciences's diluted earnings per share?

Over the five fiscal years to 2025 diluted earnings per share grew at a compound 2.3% a year.

What are the highest and lowest diluted earnings per share figures on record for Neurocrine Biosciences?

Across the 17 fiscal years on record (2009–2025), the highest was $4.67 in fiscal 2025 and the lowest -$1.63 in fiscal 2016.

How is Neurocrine Biosciences's diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Neurocrine Biosciences (NBIX) earnings per share (EPS)”, data as of 18 November 2026. https://funkfolio.com/stock/NBIX/eps

Underlying data: the company's filings with the SEC and Yahoo Finance.